Home
About
Overview
Sharing Data
ORCID
Help
History (2)
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
Targeted therapies: redefining the primary objective of phase I oncology trials.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeted therapies: redefining the primary objective of phase I oncology trials.
Targeted therapies: redefining the primary objective of phase I oncology trials. Nat Rev Clin Oncol. 2014 Sep; 11(9):503-4.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Drug Approval
Humans
Molecular Targeted Therapy
Research Design
authors with profiles
Mark J. Ratain